Adding engineered human blood vessel-forming cells to islet transplants boosted the survival of the insulin-producing cells ...

The US Food and Drug Administration has approved Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insulin aspart) for adults and pediatric patients with diabetes mellitus.

Mitochondrial stress disrupts insulin production in diabetes, but reversing the damage may restore β-cell function.

The U.S. Food and Drug Administration (FDA) recently approved Merilog (insulin-aspart-szjj) as the first rapid-acting insulin ...